These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 34440793)
21. Mitochondrial quality control in the diabetic heart. Liang Q; Kobayashi S J Mol Cell Cardiol; 2016 Jun; 95():57-69. PubMed ID: 26739215 [TBL] [Abstract][Full Text] [Related]
22. Calpains mediate isoproterenol-induced hypertrophy through modulation of GRK2. Aluja D; Inserte J; Penela P; Ramos P; Ribas C; Iñiguez MÁ; Mayor F; Garcia-Dorado D Basic Res Cardiol; 2019 Mar; 114(3):21. PubMed ID: 30915659 [TBL] [Abstract][Full Text] [Related]
23. Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Moshal KS; Singh M; Sen U; Rosenberger DS; Henderson B; Tyagi N; Zhang H; Tyagi SC Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2825-35. PubMed ID: 16877562 [TBL] [Abstract][Full Text] [Related]
24. Receptor-independent cardiac protein kinase Calpha activation by calpain-mediated truncation of regulatory domains. Kang MY; Zhang Y; Matkovich SJ; Diwan A; Chishti AH; Dorn GW Circ Res; 2010 Oct; 107(7):903-12. PubMed ID: 20689063 [TBL] [Abstract][Full Text] [Related]
25. The sarcoplasmic reticulum proteins are targets for calpain action in the ischemic-reperfused heart. Singh RB; Chohan PK; Dhalla NS; Netticadan T J Mol Cell Cardiol; 2004 Jul; 37(1):101-10. PubMed ID: 15242740 [TBL] [Abstract][Full Text] [Related]
26. Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy. Min K; Kwon OS; Smuder AJ; Wiggs MP; Sollanek KJ; Christou DD; Yoo JK; Hwang MH; Szeto HH; Kavazis AN; Powers SK J Physiol; 2015 Apr; 593(8):2017-36. PubMed ID: 25643692 [TBL] [Abstract][Full Text] [Related]
27. Uric Acid Induces Cardiomyocyte Apoptosis via Activation of Calpain-1 and Endoplasmic Reticulum Stress. Yan M; Chen K; He L; Li S; Huang D; Li J Cell Physiol Biochem; 2018; 45(5):2122-2135. PubMed ID: 29533935 [TBL] [Abstract][Full Text] [Related]
28. Mitochondrial-Shaping Proteins in Cardiac Health and Disease - the Long and the Short of It! Ong SB; Kalkhoran SB; Hernández-Reséndiz S; Samangouei P; Ong SG; Hausenloy DJ Cardiovasc Drugs Ther; 2017 Feb; 31(1):87-107. PubMed ID: 28190190 [TBL] [Abstract][Full Text] [Related]
29. Proteases in renal cell death: calpains mediate cell death produced by diverse toxicants. Schnellmann RG; Williams SW Ren Fail; 1998 Sep; 20(5):679-86. PubMed ID: 9768434 [TBL] [Abstract][Full Text] [Related]
30. [The physiological and pathological function of Ca(2 +) -dependent cysteine protease (Calpain) ]. Sakamoto Y; Akazawa H; Komuro I Clin Calcium; 2013 Apr; 23(4):519-25. PubMed ID: 23545741 [TBL] [Abstract][Full Text] [Related]
32. Activation of mitochondrial μ-calpain increases AIF cleavage in cardiac mitochondria during ischemia-reperfusion. Chen Q; Paillard M; Gomez L; Ross T; Hu Y; Xu A; Lesnefsky EJ Biochem Biophys Res Commun; 2011 Dec; 415(4):533-8. PubMed ID: 22057010 [TBL] [Abstract][Full Text] [Related]
33. Calpains as mechanistic drivers and therapeutic targets for ocular disease. Vu JT; Wang E; Wu J; Sun YJ; Velez G; Bassuk AG; Lee SH; Mahajan VB Trends Mol Med; 2022 Aug; 28(8):644-661. PubMed ID: 35641420 [TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy. Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582 [TBL] [Abstract][Full Text] [Related]
35. Activity profile of calpains I and II in chronically infarcted rat myocardium--influence of the calpain inhibitor CAL 9961. Sandmann S; Prenzel F; Shaw L; Schauer R; Unger T Br J Pharmacol; 2002 Apr; 135(8):1951-8. PubMed ID: 11959798 [TBL] [Abstract][Full Text] [Related]
36. Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy. Aluja D; Delgado-Tomás S; Ruiz-Meana M; Barrabés JA; Inserte J Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456920 [TBL] [Abstract][Full Text] [Related]
38. Calpain-dependent cleavage of N-cadherin is involved in the progression of post-myocardial infarction remodeling. Kudo-Sakamoto Y; Akazawa H; Ito K; Takano J; Yano M; Yabumoto C; Naito AT; Oka T; Lee JK; Sakata Y; Suzuki J; Saido TC; Komuro I J Biol Chem; 2014 Jul; 289(28):19408-19. PubMed ID: 24891510 [TBL] [Abstract][Full Text] [Related]
39. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension. Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859 [TBL] [Abstract][Full Text] [Related]
40. Parkin Mediates Mitophagy to Participate in Cardioprotection Induced by Late Exercise Preconditioning but Bnip3 Does Not. Yuan Y; Pan SS J Cardiovasc Pharmacol; 2018 May; 71(5):303-316. PubMed ID: 29538088 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]